MedPath

On Target Laboratories, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting

Phase 3
Completed
Conditions
Lung Neoplasms
Lung Cancer
Interventions
Drug: OTL38 for Injection
Device: Near infrared camera imaging system
First Posted Date
2020-01-27
Last Posted Date
2023-03-23
Lead Sponsor
On Target Laboratories, LLC
Target Recruit Count
112
Registration Number
NCT04241315
Locations
🇺🇸

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

🇺🇸

Stamford, Stamford, Connecticut, United States

🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 9 locations

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Phase 3
Completed
Conditions
Ovarian Cancer
Interventions
Procedure: laparotomy
Device: near infrared camera imaging system
First Posted Date
2017-06-08
Last Posted Date
2022-02-04
Lead Sponsor
On Target Laboratories, LLC
Target Recruit Count
140
Registration Number
NCT03180307
Locations
🇺🇸

University of Arizona, Tucson, Arizona, United States

🇺🇸

Mayo Clinic-Rochester, Rochester, Minnesota, United States

🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 8 locations

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

Phase 2
Completed
Conditions
Lung Neoplasms
Lung Cancer
Interventions
Drug: OTL38 for Injection
Device: Near infrared camera imaging system
Procedure: Endoscopic or Thoracic Surgery
First Posted Date
2016-08-19
Last Posted Date
2023-03-24
Lead Sponsor
On Target Laboratories, LLC
Target Recruit Count
100
Registration Number
NCT02872701
Locations
🇺🇸

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

🇺🇸

Cleveland Clinic, Cleveland, Ohio, United States

🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 3 locations

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

Phase 2
Completed
Conditions
Ovarian Cancer
Interventions
Device: Near infrared camera imaging system
Procedure: Laparotomy
First Posted Date
2014-12-16
Last Posted Date
2022-06-21
Lead Sponsor
On Target Laboratories, LLC
Target Recruit Count
48
Registration Number
NCT02317705
Locations
🇺🇸

University of CA at Irvine Chao Cancer Center, Orange, California, United States

🇺🇸

Moffitt Cancer Center, Tampa, Florida, United States

🇺🇸

Mayo Clinic-Rochester, Rochester, Minnesota, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath